IcosaMed

Curated by Signal

Developing solutions for diagnosis of cancer

Overview

Icosamed is developing solutions for the diagnosis of cancer. It has features for preventing carcinoma developments, detection of cells behavior, treatment of targeted cells only, and others. It also provides a system for dose delivery using AI technology.

Key facts

Founded: 2019
Headquarters: Neuchatel, Switzerland
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Wellness Worldwide
Provider of mental health solutions for employees
Health TechnologyNyon, Switzerland
Wemedoo
Clinical information specialist leveraging clinical data for the smart evolution of medicine
Health TechnologySteinhausen, Switzerland
Doctogo
Provider of an application for to manage doctor appointment and medications
Health TechnologyBassersdorf, Switzerland

About IcosaMed

What does IcosaMed do?

Icosamed is developing solutions for the diagnosis of cancer.

Where is IcosaMed headquartered?

IcosaMed is headquartered in Neuchatel, Switzerland.

When was IcosaMed founded?

IcosaMed was founded in 2019.

Which sector is IcosaMed in?

IcosaMed operates in Health Technology.

Who are IcosaMed's competitors?

Companies similar to IcosaMed include Wellness Worldwide, Wemedoo, and Doctogo.